CLINICAL_TRIALS
trial_result
· 2022-07-26
Clinical Trial Update: Versartis International Trial in Adults With Long-Acting Growth Hormone [Phase 2]
Summary
Phase 2 clinical trial update for adults with growth hormone deficiency evaluating a long-acting growth hormone treatment.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Versartis Inc. | Conditions: Adult Growth Hormone Deficiency | Phase 2 | Status: COMPLETED